|
1
|
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer.
|
N Engl J Med
|
2015
|
11.98
|
|
2
|
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
|
Cancer Res
|
2005
|
1.74
|
|
3
|
Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
|
Expert Rev Anticancer Ther
|
2007
|
1.14
|
|
4
|
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
|
Cancer Res
|
2006
|
1.12
|
|
5
|
EGFR-mutated lung cancer with T790M-acquired resistance in the brain and histologic transformation in the lung.
|
J Natl Compr Canc Netw
|
2013
|
1.07
|
|
6
|
The potential and rationale for COX-2 inhibitors in lung cancer.
|
Anticancer Agents Med Chem
|
2006
|
1.04
|
|
7
|
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
|
J Thorac Oncol
|
2008
|
0.95
|
|
8
|
Management of non-small-cell lung cancer in the older adult.
|
Maturitas
|
2011
|
0.91
|
|
9
|
Elevated neutrophil gelatinase-associated lipocalin contributes to erlotinib resistance in non-small cell lung cancer.
|
Am J Transl Res
|
2013
|
0.88
|
|
10
|
Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer.
|
PLoS One
|
2013
|
0.86
|
|
11
|
Non-small cell lung cancer in the elderly: defining treatment options.
|
Semin Oncol
|
2008
|
0.86
|
|
12
|
Intraventricular chemotherapy for leptomeningeal carcinomatosis from lung cancer: a feasible and beneficial treatment option?
|
J Thorac Oncol
|
2013
|
0.85
|
|
13
|
The role of targeting mammalian target of rapamycin in lung cancer.
|
Clin Lung Cancer
|
2008
|
0.85
|
|
14
|
PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.
|
Mol Cancer Res
|
2014
|
0.84
|
|
15
|
Mammalian target of rapamycin, Akt, and phosphatidylinositol 3-kinase signaling.
|
J Thorac Oncol
|
2010
|
0.75
|
|
16
|
A 75-year-old man with progressive bronchioalveolar carcinoma.
|
Semin Oncol
|
2013
|
0.75
|